Ami Organics is one of the main innovative work (R&D) driven makers of claim to fame synthetic substances with shifted end utilization, centered towards the turn of events and assembling of cutting edge drug intermediates for controlled and nonexclusive dynamic drug fixings (APIs) and New Chemical Entities (NCE) and key beginning material for agrochemical and fine synthetic substances. 

The organization is among the significant makers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. These intermediates, adding up to more than 450 items starting at 31 March 2021, discover applications in certain high-development restorative regions including hostile to retroviral, mitigating, against insane, against malignant growth, hostile to Parkinson, energizer and against coagulant, telling huge portion of the overall industry both in India and universally. 

The Pharma Intermediates business represented INR301.1 crore or 88.4% of the organization’s absolute incomes in FY2021. The organization has as of late finished the obtaining of two extra assembling offices worked by Gujarat Organics Limited (GOL) which has added additives (parabens and parabens plans having end utilization in beauty care products, creature food and individual consideration ventures) and other claim to fame synthetics (with end use in beauty care products, colors polymers and agrochemicals enterprises).